A cysteine-free 15-residue host-defense peptide analogs combines low MICs against Gram-negative bacteria with no detectable keratinocyte cytotoxicity

- 350767
Abstract - Step 2
Favorite this paper
How to cite this paper?
Abstract

Cathelicidins are host-defense peptides with activity against multidrug-resistant bacteria, but peptide length and host cell toxicity can limit their therapeutic use. Cathelicidin-PP, a 32-residue peptide, inhibits both Gram-negative and Gram-positive bacteria and is cytotoxic to human keratinocytes. We sought to develop shorter analogs that retain activity against WHO critical-priority bacteria, while reducing cytotoxicity. Twelve 15-residue analogs (Pep1–Pep12) were designed and synthesized by Fmoc solid-phase synthesis. Minimum inhibitory concentrations (MICs) were determined by broth microdilution against nine bacterial strains and Candida albicans over a concentration range of 1–128 µM. Hemolysis was assessed using human erythrocytes, and HaCaT keratinocyte viability was measured using the MTT assay. Concentrations causing 50% hemolysis (HC₅₀) or a 50% reduction in HaCaT cell viability (IC₅₀) were estimated by four-parameter logistic regression when supported by the concentration–response data. All 12 analogs inhibited carbapenem-resistant Acinetobacter baumannii at 1–64 µM, compared with 2 µM for the wild-type (WT) peptide. Pep12 was the only analog to inhibit Staphylococcus aureus, with an MIC of 64 µM compared with 4 µM for the WT peptide. Pep2, Pep3, Pep8, Pep11, and Pep12 inhibited both Escherichia coli and Pseudomonas aeruginosa, with MICs of 2–8 µM. The corresponding MICs of the WT peptide were 2 and 4 µM, respectively. Eight analogs inhibited C. albicans at 32–64 µM, whereas the MIC of the WT peptide was >64 µM. Pep8 inhibited A. baumannii, E. coli, P. aeruginosa, and Klebsiella pneumoniae at 1, 2, 4, and 8 µM, respectively, compared with 2, 2, 4, and 2 µM for the WT peptide. None of the analogs caused 50% hemolysis or reduced HaCaT cell viability by 50% at concentrations up to 128 µM. Both HC₅₀ and HaCaT IC₅₀ therefore exceeded 128 µM for all analogs. The WT peptide had a HaCaT IC₅₀ of 4.8 µM (SE, 0.3 µM). These findings show that the toxicity of cathelicidin-PP can be separated from its Gram-negative activity in a short sequence, giving a new, promising candidate scaffold against carbapenem-resistant infections, as shown by Pep8.

Funding
  • FAPDF
  • CNPq
  • CAPES
  • FINEP
  • FUB/UnB

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 Universidade de Brasília (UNB)
  • 2 State University of Norte Fluminense | (State University of Norte Fluminense)
  • 3 Universidade Católica de Brasília | (Catholic University of Brasília)
  • 4 Universidade Católica Dom Bosco | (Dom Bosco Catholic University)
Track
  • Bioprospecting and Technological Innovation
Keywords
Cathelicidin
Antimicrobial Cationic Peptides
Acinetobacter baumannii
Drug Resistance
Antifungal Agents